| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Pridgen William is a Director at Dogwood Therapeutics, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $80K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 15,335 | $1.30 | $19,992.24 | +41.8% | -42.8% | -84.6% | |
| May 18, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 241 | $4.50 | $1,084.50 | +0.7% | +46.8% | -75.9% | |
| May 17, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 13,450 | $4.38 | $58,913.69 | +58.4% | +85.0% | -77.0% | |
| Mar 29, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 600 | $4.94 | $2,964.48 | +2.7% | -12.5% | -92.5% | |
| Mar 23, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 2,197 | $5.46 | $12,001.55 | +10.9% | -19.4% | -94.1% | |
| Jan 27, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 4,180 | $5.98 | $24,997.65 | +28.7% | -33.8% | -94.4% | |
| Jan 3, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 2,215 | $5.43 | $12,033.87 | +18.0% | -16.8% | -95.8% | |
| Dec 21, 2021 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 8,827 | $5.66 | $49,997.01 | +252.2% | -2.1% | -95.8% | |
| Jul 7, 2021 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 942 | $6.32 | $5,950.61 | +0.1% | -21.3% | -31.0% | |
| Jan 29, 2021 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 3,500 | $7.47 | $26,145.00 | New | - | - |